Table 1

Characteristics of the study population

Above LTBelow LT
Controls (n=10)COPD (n=11)Controls (n=7)COPD (n=7)
Clinical data
 Age (years)66.5±4.367.2±8.456.7±8.965.0±6.5
 BMI (kg/m2)26.2±2.424.8±3.227.3±7.025.7±2.5
 FFMI (kg/m2)21.0±2.619.2±1.422.4±5.319.3±1.8
Lung function and peak exercise data
 FEV1 (l)2.9±0.41.4±0.3***2.8±0.51.6±0.3***
 FEV1 (% ref)90.3±6.844.8±7.7***92.5±5.649.9±3.8***
 Tlco (% ref)89.1±12.456.7±16.1**91.4±6.563.9±8.7**
 Pao2 at rest (mm Hg)77±767±7**83±366±5***
 V′o2peak (l/min)1.67±0.231.23±0.18**1.73±0.341.34±0.29*
 V′o2peak (% ref)91±3.368±10.4***90±2.371±11.9**
 V′o2 at LT (l/min)1.03±0.130.73±0.15**0.82±0.101.06±0.26**
 Work rate peak (W)132 ±2388±17**143±3599±27*
 V′epeak (l/min)64.9±9.348.1±4.1***74.9±16.253.8±16.5**
Skeletal muscle results at rest
 mtDNA/nDNA1241±1841104±1831227±2101082±229
 PGC-1α mRNA (arbitrary units)1.02±0.120.86±0.440.99±0.240.76±0.16
 MnSOD (U/mg)1.10±0.371.53±0.51*0.9±0.21.33±0.39*
Constant work load exercise data
 Work rate (W)86±1457±25***72±2050±14**
 V′o2peak (l/min)1.55±0.141.13±0.26**0.83±0.190.65±0.15*
 V′epeak (l/min)61.3±5.744.6±5.9**36.7±9.127.9±8.5*
 End exercise dyspnoea, CR105.0±2.24.1±1.43.6±1.82.0±1.0
 End exercise leg fatigue, CR107.5±1.86.8±1.64.7±2.12.4±1.5*
 Total V′o2 (mmol)2122±2801515±227***1113±223865±187***
 Estimated ROS production (mmol/kg)0.76±0.151.45±0.24***0.4±0.10.81±0.16***
 Pao2 peak exercise (mm Hg)80±466±6***87±567±7***
 Lactate end (mEq/l)5.4±0.75.0±0.62.4±0.32.8±0.5
  • Values shown are mean±SD.

  • *p<0.05; **p<0.01; ***p<0.001 vs controls.

  • BMI, body mass index; CR10, Borg CR10 scale; FEV1, forced expiratory volume in 1 s; FFMI, fat-free mass index; LT, lactate threshold; MnSOD, manganese superoxide dismutase; mtDNA, mitochondrial DNA; nDNA, nuclear DNA; Pao2, arterial oxygen tension; % ref, percentage of predicted values; PGC-1α, peroxisome proliferator-activated receptor-γcoactivator-1α; ROS, reactive oxygen species; Tlco, carbon monoxide transfer factor; V′o2 oxygen uptake; V′e, minute ventilation.